See every side of every news story
Published loading...Updated

Leerink Partners Upgrades Progyny (NASDAQ:PGNY) to "Outperform"

Summary by marketbeat.com
Leerink Partners raised shares of Progyny from a "market perform" rating to an "outperform" rating and set a $28.00 target price for the company in a research report on Tuesday.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Tuesday, July 8, 2025.
Sources are mostly out of (0)